Clinical efficacy of low dose flutamide plus diane-35 in the treatment of idiopathic hirsutism and polycystic ovary syndrome

Ginekologia Polska

Volumn 84, Issue 4, 2013, Pages 258-262

  Boztosun, Abdullah ^a   Açmaz, Gökhan ^b   Ozturk, Ahmet ^c   Müderris, Iptisam Ipek ^c  

^a CUMHURIYET UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^b Kayseri Training and Education Hospital of Medicine   (Turkey)

^c ERCIYES UNIVERSITY MEDICAL FACULTY   (Turkey)

Author keywords

Diane 35a; Flutamid; Hirsutism

Indexed keywords

EID: 84879208337     PISSN: 00170011     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. McKenna T. The use of anti-androgens in the treatment of hirsutism. Clin Endocrinol. 1991, 35, 1-3.
2. Knochenhauer E, Key T, Kahsar-Miller M, et al. Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study. J Clin Endocrinol Metab. 1998, 83, 3078-3082.
3. Couzinet B, Pholsena M, Young J, Schaison G. The impact of a pure anti-androgen (flutamide) on LH, FSH, androgens and clinical status in idiopathic hirsutism. Clin Endocrinol (Oxf). 1993, 39, 157-162.
4. Cesur V, Kamel N, Uysal A, Erdogan G, Kaskal N. The use of antiandrogenflutamide in the treatment of hirsutism. Endocr J. 1994, 41, 573-577.
5. Azziz R, Carmina E, Sawaya M. Idiopathic hirsutism. Endocr Rev. 2000, 21, 347-362.
6. Dodin S, Faure N, Cédrin I, et al. Clinical efficacy and safety of low dose flutamide alone and combined with an oral contraceptive for the treatment of idiopathic hirsutism. Clin Endocrinol. 1995, 43, 575-582.
7. Biffignandi P, Massuchettic C, Molinatti G. Female hirsutism pathophysiological considerations and therapeutic implications. Endocrinol Rev.1984, 5, 498-513.
8. Oláh K. The modern management of hirsutism. Rev Oncol Pract. 2004, 4, 211-220.
9. Murphy A, Cropp C, Smith B, et al. Effect of low-dose oral contraceptive on gonadotropins, androgens, and sex hormone binding globulin in non hirsute women. Fertil Steril. 1990, 53, 35-39.
10. Hatch R, Rosenfield R, Kim M, Treway D. Hirsutism: implications, etiology, and management. Am J Obstet Gynecol.1981, 140, 815-830.
11. Aziz R, Carmina E. Idiopathic hirsutism: definition, prevalence and inheritance. In: Androgen Excess Disorders in Women, pp 529-534. Eds. Azziz A, Nestler J, Dewailly D. Philadelphia: Lippincott-Raven Publishing, 1997.
12. Azziz R, Ochoa T. Idiopathic hirsutism (IH): an uncommon cause of hirsutism in Alabama. 53rd Annual Meeting of the American Society of Reproductive Medicine, Cincinnati, USA, October 18-221997. Abstract P 075.
13. Rotterdam ESHRE/ASRM-sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long term health risks related to polycystic ovary syndrome. Human Reprod. 2004, 19, 41-47.
14. Balen A, Laven J, Tan S, Dewailly D. Ultrasound assessment of the polycystic ovary: international consensus definitions. Hum Reprod Update. 2003, 9, 505-514.
15. Azziz R, Carmina E, Dewailly D, et al. The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report. Fertil Steril. 2009, 91, 456-488.
16. De Leo V, Lanzetta D, D'Antona D, [et al.]. Hormonal Effects of Flutamide in Young Women with Polycystic Ovary Syndrome. J Clin Endocrinol Metab. 1998, 83, 99-102.
17. Taner C, Inal M, Basogul O, et al. Comparison of the Clinical Efficacy and Safety of Flutamide versus Flutamide plus an Oral Contraceptive in the Treatment of Hirsutism. Gynecol Obstet Invest. 2002, 54, 105-108.
18. Moghetti P, Castello R, Negri C, et al. Flutamide in the treatment of hirsutism: long-term clinical effects, endocrine changes, and androgen receptor behavior. Fertil Steril. 1995, 64, 511-517.
19. Müderris I, Bayram F, Sahin Y, Kelestimur F. A comparison between two doses of flutamide (250mg/d and 500mg/d) in the treatment of hirsutism. Fertil Steril. 1997, 68, 644-647.
20. Aziz R, Ochoa T, Bradley E, et al. Luprolide and estrogen vs oral contraceptive pills for the treatment of hirsutism: a prospective randomized study. J Clin Endocrinol Metab. 1995, 80, 3406-3411.
21. Beigi A, Sobhi A, Zarrinkoub F. Finasteride versus cyproterone acetate-estrogen regimens in the treatment of hirsutism. Int JGynaecol Obstet. 2004, 87, 29-33.
22. Calaf J, López E, Millet A, et al. Espinósand the Spanish Working Group for HirsutismLong- Term Efficacy and Tolerability of Flutamide Combined with Oral Contraception in Moderate to Severe Hirsutism: A 12-Month, Double-Blind, Parallel Clinical Trial. J Clin Endocrinol Metab. 2007, 92, 3446-3452.